Good post Hoofa What next? 1 - Word was out that on 5th to 7trh Feb we were to be considered for some special code (or something) to make insurance claiming easier in the US. Hopefully that will occur and we will hear the result next week. 2 - The 'business' part of the year has been going for a few weeks now. The FDA announcement came on 20 Dec when there was no activity business wise for the next few weeks. Hopefully we will soon see some interest from pharmaceutical companies on using Hepafat for drug testing. Any contracts in this regard would do a lot for our SP. 3 - Management had indicated a Newsletter about the end of January. If we are having any success with 1 or 2 above then it would be sensible to wait until something is concrete before a Newsletter is put out. 4 - Around end February we will get the HY report. The actual results will not have anything we have not seen from the quarterlies but there may be some insights into future development. It is even possible that if there is no quick development in 1 or 2 then the HY might do the task of the Newsletter and so NO newsletter. 5 If 4 is the situation (hopefully unlikely) then the SP will pull back more BUT it will not stop the advancement of RHT - just slow it down. I am still trying to fill my order at 6.9c but save a bit for cheap buying in case 4 occurs.
RHT Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
